Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Companyâs Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.
äŒæ¥ã³ãŒãNAGE
äŒç€ŸåNiagen Bioscience Inc
äžå Žæ¥Jun 25, 2007
æé«çµå¶è²¬ä»»è
ãCEOãFried (Robert N)
åŸæ¥å¡æ°104
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jun 25
æ¬ç€Ÿæåšå°10900 Wilshire Blvd Suite 600
éœåžLOS ANGELES
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·90024
é»è©±çªå·13103886706
ãŠã§ããµã€ãhttps://www.niagenbioscience.com/
äŒæ¥ã³ãŒãNAGE
äžå Žæ¥Jun 25, 2007
æé«çµå¶è²¬ä»»è
ãCEOãFried (Robert N)